002294:SHE
Shenzhen Salubris Pharmaceuticals Co Ltd
CN¥30.84
arrow_upward
+0.85%(+0.26) 1D
Okt 16, 3:04:54 PM GMT+8 · CNY
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 002294...
Buksan
CN¥30.83
Mataas
CN¥31.80
Mababa
CN¥30.82
Mkt. cap
34.38B
Avg. na dami
9.55M
Dami
27.91M
Dividend
1.78%
Bawat tatlong buwang dividend
CN¥0.14
Petsa ng ex-dividend
May 26, 2026
P/E ratio
51.05
Mataas nang 52-wk
CN¥70.99
Mababa nang 52-wk
CN¥29.25
EPS
CN¥0.60
Mga natitirang share
1.11B
Bilang ng mga empleyado
4K
Buksan
CN¥30.83
Mataas
CN¥31.80
Mababa
CN¥30.82
Mkt. cap
34.38B
Avg. na dami
9.55M
Dami
27.91M
Dividend
1.78%
Bawat tatlong buwang dividend
CN¥0.14
Petsa ng ex-dividend
May 26, 2026
P/E ratio
51.05
Mataas nang 52-wk
CN¥70.99
Mababa nang 52-wk
CN¥29.25
EPS
CN¥0.60
Mga natitirang share
1.11B
Bilang ng mga empleyado
4K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
NDTV Profit
·
4 oras ang nakalipas
84 Percent Stocks In Correction, Yet S&P 500 Nears Record High: What's Behind The 'Bull-Bear' Market?
investingLive
·
21 oras ang nakalipas
S&P 500 analysis and forecast after the "AI bubble" panic
Bloomberg.com
·
6 araw ang nakalipas
S&P 500 Wavers as Earnings Bets Offset Chip Rout: Markets Wrap
MarketWatch
·
1 buwan ang nakalipas
The S&P 500 keeps climbing on days when stocks broadly struggle. Here’s what’s going on.
Profile
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company.
Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.
Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
Tungkol sa Shenzhen Salubris Pharmaceuticals Co Ltd